Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125989182 | 12598918 | 2 | F | 200808 | 20160722 | 20160726 | 20160926 | PER | US-ASTRAZENECA-2013SE91341 | ASTRAZENECA | 842.00 | MON | F | Y | 86.20000 | KG | 20160926 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125989182 | 12598918 | 1 | PS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 73416 | 22200 | 2 | MG | POWDER FOR SUSPENSION FOR INJECTION | /wk | ||||||
| 125989182 | 12598918 | 2 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 73416,FL0144 | 22200 | 2 | MG | POWDER FOR SUSPENSION FOR INJECTION | /wk | ||||||
| 125989182 | 12598918 | 3 | SS | OMEPRAZOL | OMEPRAZOLE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 125989182 | 12598918 | 4 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | U | 0 | SUSPENSION FOR INJECTION IN PRE-FILLED PEN | ||||||||
| 125989182 | 12598918 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | 500 | MG | TABLET | QID | ||||||||
| 125989182 | 12598918 | 6 | C | WELCHOL | COLESEVELAM HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125989182 | 12598918 | 7 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 125989182 | 12598918 | 8 | C | FUROSEOMIDE | 2 | Oral | 0 | 20 | MG | QD | |||||||||
| 125989182 | 12598918 | 9 | C | IRBESARTAN. | IRBESARTAN | 1 | Oral | 0 | 75 | MG | QD | ||||||||
| 125989182 | 12598918 | 10 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | 100 | MG | QD | ||||||||
| 125989182 | 12598918 | 11 | C | OXYBUTYNIN | OXYBUTYNIN | 1 | Oral | 0 | 5 | MG | QD | ||||||||
| 125989182 | 12598918 | 12 | C | COREG | CARVEDILOL | 1 | Oral | 0 | |||||||||||
| 125989182 | 12598918 | 13 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 0 | 81 | MG | QD | ||||||||
| 125989182 | 12598918 | 14 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
| 125989182 | 12598918 | 15 | C | FIBER | PSYLLIUM HUSK | 1 | 52G | 0 | |||||||||||
| 125989182 | 12598918 | 16 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | 0 | |||||||||||
| 125989182 | 12598918 | 17 | C | IRON | IRON | 1 | Oral | 0 | |||||||||||
| 125989182 | 12598918 | 18 | C | PRECOSE | ACARBOSE | 1 | 0 | ||||||||||||
| 125989182 | 12598918 | 19 | C | PRAMLINTIDE ACETATE | PRAMLINTIDE ACETATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125989182 | 12598918 | 1 | Type 2 diabetes mellitus |
| 125989182 | 12598918 | 2 | Type 2 diabetes mellitus |
| 125989182 | 12598918 | 3 | Gastrooesophageal reflux disease |
| 125989182 | 12598918 | 4 | Type 2 diabetes mellitus |
| 125989182 | 12598918 | 5 | Type 2 diabetes mellitus |
| 125989182 | 12598918 | 7 | Blood cholesterol |
| 125989182 | 12598918 | 8 | Fluid retention |
| 125989182 | 12598918 | 9 | Hypertension |
| 125989182 | 12598918 | 10 | Gout |
| 125989182 | 12598918 | 11 | Renal disorder |
| 125989182 | 12598918 | 12 | Hypertension |
| 125989182 | 12598918 | 13 | Cardiac disorder |
| 125989182 | 12598918 | 14 | Cardiac disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125989182 | 12598918 | Blood glucose increased | |
| 125989182 | 12598918 | Device malfunction | |
| 125989182 | 12598918 | Injection site haemorrhage | |
| 125989182 | 12598918 | Injection site reaction | |
| 125989182 | 12598918 | Underdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125989182 | 12598918 | 1 | 2013 | 0 | ||
| 125989182 | 12598918 | 2 | 2014 | 0 | ||
| 125989182 | 12598918 | 4 | 200808 | 0 |